| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |